INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 60 filers reported holding INOTEK PHARMACEUTICALS CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $43,000 | -89.1% | 34,900 | -88.0% | 0.06% | -90.4% |
| Q2 2017 | $395,000 | -58.7% | 290,800 | -39.1% | 0.68% | -45.9% |
| Q1 2017 | $956,000 | -13.5% | 477,863 | +163.8% | 1.26% | -0.9% |
| Q4 2016 | $1,105,000 | -25.7% | 181,172 | +15.5% | 1.27% | +7.6% |
| Q3 2016 | $1,487,000 | +35.9% | 156,864 | -49.9% | 1.18% | +25.4% |
| Q2 2016 | $1,094,000 | -12.9% | 313,051 | +74.4% | 0.94% | -28.6% |
| Q1 2016 | $1,256,000 | +281.8% | 179,551 | +393.0% | 1.32% | +441.6% |
| Q4 2015 | $329,000 | – | 36,421 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,802,000 | $3,207,000 | 1.13% |
| SENZAR ASSET MANAGEMENT, LLC | 781,922 | $1,392,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 401,764 | $715,000 | 0.10% |
| FT Options LLC | 20,000 | $36,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 367,300 | $654,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 139,731 | $249,000 | 0.04% |
| FT Options LLC | 14,900 | $7,000 | 0.01% |
| MERIDIAN INVESTMENT COUNSEL INC. | 20,000 | $37,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,500,000 | $2,670,000 | 0.01% |
| Point72 Asset Management, L.P. | 635,465 | $1,131,000 | 0.01% |